According to WuXi Biologics's latest financial reports the company's current revenue (TTM ) is ยฃ1.85 Billion. In 2023 the company made a revenue of ยฃ1.85 Billion an increase over the revenue in the year 2022 that were of ยฃ1.70 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 | ยฃ1.85 B | 8.85% |
2022 | ยฃ1.70 B | 37.09% |
2021 | ยฃ1.24 B | 87.66% |
2020 | ยฃ0.66 B | 50.9% |
2019 | ยฃ0.44 B | 54.74% |
2018 | ยฃ0.28 B | 48.1% |
2017 | ยฃ0.19 B | 74.7% |
2016 | ยฃ0.10 B | 65.72% |
2015 | ยฃ66.33 M | 60.37% |
2014 | ยฃ41.36 M |